Wyeth must pay $134.1 million in menopause drug lawsuit
Wyeth must pay $134.1 million, including $99 million in punitive damages, over its mishandling of menopause drugs that helped cause three Nevada women’s cancers, a jury ruled.
News Tagged ‘breast cancer risks’
Prempro lawsuit goes to the jury
After four weeks of testimony and a full day of closing arguments, jurors will begin deliberating this morning to decide whether pharmaceutical giant Wyeth is responsible for the breast cancer suffered by three Northern Nevada women who took the company’s hormone replacement drugs.
HRT sales rep whistleblower admits improper promotion
The Reno trial involving three breast cancer survivors who are suing Wyeth is now nearing the end of its fourth week. The Nevada plaintiffs are suing Wyeth, the manufacturer of Prempro and Premarin, after they each developed breast cancer attributed to their long-term use of combination hormone replacement drugs.